Levodopa effect on [18F]fluorodopa influx to brain: normal volunteers and patients with Parkinson's disease
- 4 June 2004
- journal article
- clinical trial
- Published by Hindawi Limited in Acta Neurologica Scandinavica
- Vol. 110 (3) , 188-195
- https://doi.org/10.1111/j.1600-0404.2004.00299.x
Abstract
Objectives – Levodopa is the immediate precursor of dopamine and the substrate for DOPA decarboxylase, an enzyme subject to regulation in living brain. To test whether this regulation changes in disease, we used Positron Emission Tomography (PET) with parametric mapping to measure the effect of levodopa on the net clearance of [18F]fluorodopa to brain (K, ml/g/min). Methods – Five patients with early Parkinson's disease with pause of medication for 3 days and six age‐matched healthy volunteers were studied in a baseline condition and after levodopa challenge. Results – Levodopa (200 mg as Sinemet) increased the magnitude of the net clearance K in the left and right putamen of the healthy volunteers by 11% relative to the baseline condition. In contrast, resumption of medication with levodopa did not significantly alter the magnitude of K in putamen of the Parkinson's disease patients. Compartmental analysis was used to probe the physiological basis of the activation of K: levodopa treatment increased by 15% the apparent distribution volume of [18F]fluorodopa in cerebellum (, ml/g) of both patients and control subjects, without significantly altering the unidirectional blood–brain clearance (, ml/g/min) or the relative activity of DOPA decarboxylase (, min−1) in putamen. Conclusion – We conclude that levodopa treatment increases the distribution volume of [18F]fluorodopa in brain, increasing its availability for utilization in dopamine terminals. We speculate that levodopa act as a direct beta‐adrenergic agonist at receptors regulating the permeability of the blood–brain barrier to levodopa. However, the PET analytical method was without sufficient power to detect the consequent increase in magnitude of K in brain of only five Parkinson's disease subjects.Keywords
This publication has 43 references indexed in Scilit:
- Evidence for impaired presynaptic dopamine function in parkinsonian patients with motor fluctuationsJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 2000
- Statistical parametric mapping with 18F-dopa PET shows bilaterally reduced striatal and nigral dopaminergic function in early Parkinson's diseaseJournal of Neurology, Neurosurgery & Psychiatry, 1999
- Differential effects of levodopa on dopaminergic function in early and advanced Parkinson's diseaseAnnals of Neurology, 1997
- Wearing‐off fluctuations in Parkinson's disease: Contribution of postsynaptic mechanismsAnnals of Neurology, 1994
- ?-Adrenergic Effects on Plasma and Brain Large Neutral Amino Acids Are Unaltered by Chronic Administration of AntidepressantsJournal of Neurochemistry, 1991
- Nigrostriatal function in humans studied with positron emission tomographyAnnals of Neurology, 1989
- Uneven Pattern of Dopamine Loss in the Striatum of Patients with Idiopathic Parkinson's DiseaseNew England Journal of Medicine, 1988
- Graphical Evaluation of Blood-to-Brain Transfer Constants from Multiple-Time Uptake Data. GeneralizationsJournal of Cerebral Blood Flow & Metabolism, 1985
- Calculation of cerebral glucose phosphorylation from brain uptake of glucose analogs in vivo: A re-examinationBrain Research Reviews, 1982
- Adrenergic and Cholinergic Receptors of Cerebral MicrovesselsJournal of Cerebral Blood Flow & Metabolism, 1981